Capmatinib

Status:

Do Not Prescribe (DNP)

Decision Date:

June 2023

Comments

DNP: NICE TA884 - Capmatinib for treating advanced non-small-cell lung cancer with MET exon 14 skipping (terminated appraisal). NHSE commissioned

search again